Melvin K Spigelman - Net Worth and Insider Trading
Melvin K Spigelman Net Worth
The estimated net worth of Melvin K Spigelman is at least $5 Million dollars as of 2024-11-13. Melvin K Spigelman is the Director of The Medicines Co and owns about 53,133 shares of The Medicines Co (MDCO) stock worth over $5 Million. Details can be seen in Melvin K Spigelman's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Melvin K Spigelman has not made any transactions after 2018-05-25 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Melvin K Spigelman
Melvin K Spigelman Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Melvin K Spigelman owns 1 companies in total, including AN2 Therapeutics Inc (ANTX) .
Click here to see the complete history of Melvin K Spigelman’s form 4 insider trades.
Insider Ownership Summary of Melvin K Spigelman
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ANTX | AN2 Therapeutics Inc | 2022-03-24 | director |
Melvin K Spigelman Latest Holdings Summary
Melvin K Spigelman currently owns a total of 1 stock. Melvin K Spigelman owns 53,133 shares of The Medicines Co (MDCO) as of May 25, 2018, with a value of $5 Million.
Latest Holdings of Melvin K Spigelman
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| MDCO | The Medicines Co | 2018-05-25 | 53,133 | 84.90 | 4,510,992 |
Holding Weightings of Melvin K Spigelman
Melvin K Spigelman Form 4 Trading Tracker
According to the SEC Form 4 filings, Melvin K Spigelman has made a total of 0 transactions in The Medicines Co (MDCO) over the past 5 years. The most-recent trade in The Medicines Co is the sale of 7,500 shares on May 25, 2018, which brought Melvin K Spigelman around $241,500.
Insider Trading History of Melvin K Spigelman
- 1
Melvin K Spigelman Trading Performance
Melvin K Spigelman Ownership Network
Ownership Network List of Melvin K Spigelman
Ownership Network Relation of Melvin K Spigelman
Melvin K Spigelman Owned Company Details
What does AN2 Therapeutics Inc do?
Who are the key executives at AN2 Therapeutics Inc?
Melvin K Spigelman is the director of AN2 Therapeutics Inc. Other key executives at AN2 Therapeutics Inc include 10 percent owner Ra Capital Healthcare Fund Lp , 10 percent owner Adjuvant Global Health Technology Fund De, L.p. , and Chief Strategy Officer Kevin Michael Krause .
AN2 Therapeutics Inc (ANTX) Insider Trades Summary
Over the past 18 months, Melvin K Spigelman made no insider transaction in AN2 Therapeutics Inc (ANTX). Other recent insider transactions involving AN2 Therapeutics Inc (ANTX) include a net sale of 223,880 shares made by Kabeer Aziz , a net sale of 223,880 shares made by Adjuvant Global Health Technology Fund De, L.p. , and a net sale of 1,747,316 shares made by Ra Capital Healthcare Fund Lp .
In summary, during the past 3 months, insiders sold 0 shares of AN2 Therapeutics Inc (ANTX) in total and bought 1,500,000 shares, with a net purchase of 1,500,000 shares. During the past 18 months, 4,090,725 shares of AN2 Therapeutics Inc (ANTX) were sold and 3,287,778 shares were bought by its insiders, resulting in a net sale of 802,947 shares.
AN2 Therapeutics Inc (ANTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
AN2 Therapeutics Inc Insider Transactions
Melvin K Spigelman Mailing Address
Above is the net worth, insider trading, and ownership report for Melvin K Spigelman. You might contact Melvin K Spigelman via mailing address: The Medicines Company, 8 Campus Drive, Parsippany Nj 07054.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
